July 14, 2021 – Hoboken, NJ – The American Society of Hematology (ASH), the world’s largest professional society concerned with the causes and treatments of blood disorders, and global research and education leader Wiley today announced that, starting in January 2022, Wiley will publish ASH’s industry-leading newsmagazine, ASH Clinical News.
First published in October 2014, ASH Clinical News is a leading source of news and opinion content for the hematology and oncology community, reaching a global audience of more than 75,000 professionals each month in print and online. With more than 300 articles published per year, the magazine has an unparalleled impact on the industry, providing ASH members and hematology professionals alike with news and insights tailored to their needs, with a focus on the latest advances in the field.
“As the largest professional society for hematologists, ASH remains committed to delivering the most important and relevant information to help our members conquer blood diseases worldwide,” said ASH President Martin S. Tallman, MD. “ASH Clinical News is a key service to the profession, and we are delighted that Wiley will begin publication in 2022.”
“Science communication has never been more important – we see that among the 40+ newsmagazines we publish. We’re delighted to work with ASH on its flagship newsmagazine to bring world-class content to the hematology-oncology community and beyond,” said Jay Flynn, Wiley SVP & Chief Product Officer, Research.
Under an agreed strategy between ASH and Wiley, ASH Clinical News will accelerate its development as a multimedia brand. Across all formats, the publication will focus on maintaining its excellent reputation for high quality and timely content as the discipline evolves.
ASH’s current Publisher, AMC Media Group, will continue to publish ASH Clinical News through the end of 2021, and will remain the contact point for advertisers and sponsors for the remainder of 2021 issues. Wiley has selected Pharmaceutical Media Inc (PMI) to serve as its sales agent and contact point for advertisers and sponsors for ASH Clinical News issues in 2022 and beyond.